Clinical trial
A Pilot Clinical Trial of CMV pp65 Specific T Cell Adoptive Immunotherapy in Patients Who Have Undergone Allogeneic Stem Cell Transplantation for Malignant Disease
NCT00611637 is registered in ClinicalTrials.gov with H. Kim Lyerly as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Clinical Trial of CMV pp65 Specific T Cell Adoptive Immunotherapy in Patients Who Have Undergone Allogeneic Stem Cell Transplantation for Malignant Disease
- Lead sponsor
- H. Kim Lyerly
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- August 31, 2005
- Completion date
- June 30, 2008
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allogeneic stem cell transplantation